FermaPro Black Garlic (Allium sativum)

FermaPro Black Garlic is a fermented form of Allium sativum standardized to elevated S-allylcysteine (SAC), reaching 19.4 mg/100g compared to 2.4 mg/100g in fresh garlic. SAC drives its primary mechanisms by inhibiting ACE activity and suppressing NF-κB/MAPK inflammatory signaling pathways.

Origin & History

FermaPro Black Garlic is a branded form of Allium sativum processed using proprietary high-performance aging at 60-90°C and 70-90% humidity for weeks to months. This controlled aging triggers the Maillard reaction, transforming fresh garlic's pungent compounds into stable antioxidants with 3-6 times higher polyphenols and S-allyl cysteine (SAC) content.

Historical & Cultural Context

Black garlic is a modern processed food that emerged in the 20th century, popularized in Japan and Korea for enhanced flavor and mild health benefits. Unlike fresh garlic's millennia-long use in Traditional Chinese Medicine and Ayurveda, black garlic processing represents recent culinary innovation rather than traditional medicine.

Health Benefits

• Antioxidant support through elevated SAC (19.4 mg/100g vs 2.4 mg/100g in fresh garlic) and melanoidins - evidence from preclinical studies only
• Anti-inflammatory activity via NF-κB/MAPK pathway inhibition - demonstrated in cell/animal models
• Potential cardiovascular support through ACE inhibition mechanisms - preclinical evidence only
• Hepatoprotective effects observed in animal models - no human clinical data
• Anticancer properties through apoptosis induction via Bax/Bcl-2 modulation - limited to preclinical research

How It Works

SAC (S-allylcysteine) inhibits angiotensin-converting enzyme (ACE), reducing conversion of angiotensin I to the vasoconstrictive angiotensin II, thereby supporting healthy blood pressure. Fermentation-derived melanoidins and SAC collectively suppress NF-κB and MAPK signaling cascades, downregulating pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, SAC scavenges reactive oxygen species (ROS) and upregulates endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for FermaPro Black Garlic or branded black garlic extracts. All evidence comes from preclinical cell culture and animal studies examining general black garlic compounds' antioxidant, anti-inflammatory, and anticancer mechanisms.

Clinical Summary

The majority of evidence supporting FermaPro Black Garlic comes from in vitro cell studies and rodent models, with limited randomized controlled trials in humans specifically using this fermented form. One small human pilot study on aged black garlic extract (n=19) observed modest reductions in LDL cholesterol and improvements in antioxidant status over 12 weeks, though sample sizes were insufficient for definitive conclusions. Preclinical models consistently show ACE inhibitory activity and NF-κB suppression, but translation to human clinical outcomes has not been rigorously established. Consumers should recognize that current evidence is preliminary and does not yet support strong cardiovascular outcome claims.

Nutritional Profile

Black garlic produced via Maillard fermentation/aging process exhibits significantly altered nutritional composition compared to fresh garlic. Macronutrients per 100g (approximate): carbohydrates 55-65g (predominantly fructooligosaccharides and reducing sugars formed during aging), protein 6-9g (including bioavailable peptide fragments from proteolysis during fermentation), fat <1g, moisture 35-45g, fiber 3-5g. Key bioactive compounds: S-Allylcysteine (SAC) 19.4 mg/100g — water-soluble, highly bioavailable organosulfur compound (estimated oral bioavailability ~98% vs ~3% for allicin-dependent compounds in fresh garlic); S-Allylmercaptocysteine (SAMC) present at elevated concentrations vs fresh garlic; allicin absent or negligible due to heat/moisture transformation during aging process. Melanoidins (brown nitrogenous polymers from Maillard reaction) present as major antioxidant contributors — concentrations vary by fermentation conditions but typically represent 5-15% of dry weight. Total polyphenol content: approximately 40-80 mg GAE/100g (2-7x higher than fresh garlic). ORAC/antioxidant capacity elevated 10-19x vs fresh garlic in vitro. Micronutrients: manganese (~1.7 mg/100g), vitamin B6 (~1.2 mg/100g), vitamin C (reduced vs fresh due to heat, approximately 5-10 mg/100g), calcium (~180 mg/100g), phosphorus (~150 mg/100g), selenium trace amounts (~14 mcg/100g). Fructans and FOS content partially degraded vs fresh garlic. SAC bioavailability is the primary pharmacokinetically relevant parameter; FermaPro designation suggests standardized fermentation process, implying consistent SAC yield at stated 19.4 mg/100g concentration.

Preparation & Dosage

No clinically studied dosage ranges have been established for FermaPro Black Garlic or black garlic extracts in humans. Preclinical studies reference SAC standardization (19.4 mg/100g) and 5-HMF content (0.25-8 g/kg), but therapeutic doses remain unspecified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Coenzyme Q10, Omega-3 fatty acids, Vitamin E, Resveratrol, Quercetin

Safety & Interactions

Black garlic is generally well-tolerated, with mild gastrointestinal effects such as bloating or nausea reported at higher doses; its fermented form is considered easier to digest than raw garlic. Due to SAC's ACE-inhibitory and platelet-inhibiting properties, concurrent use with antihypertensive medications (e.g., ACE inhibitors, ARBs) or anticoagulants (e.g., warfarin, clopidogrel) may produce additive effects and warrants medical supervision. Individuals scheduled for surgery should discontinue use at least two weeks prior due to potential antiplatelet activity. Safety data in pregnant or breastfeeding women is insufficient, and use during pregnancy should be avoided without physician guidance.